ResMed Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -75.17. In total, the insiders bought 249.05K and sold 128.19M RMD shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-75.17
Buy 249.05K shares
Sell 128.19M shares
55% Buy Activity
Weak Negative Correlation
Buy Signal Low Confidence
Jun 08, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -75.17.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Nov 03, 2025
Buy
ResMed Common Stock
M-Exempt
Sandercock Brett
Chief Financial Officer
C-Suite Officer 2 000
Value: $203.3K
Nov 03, 2025
Sell
ResMed Common Stock
S-Sale
Sandercock Brett
Chief Financial Officer
C-Suite Officer 3 000
Value: $742.6K
Nov 03, 2025
Buy
ResMed Common Stock Options
M-Exempt
Sandercock Brett
Chief Financial Officer
C-Suite Officer 2 000
Value: $203.3K
Oct 07, 2025
Buy
ResMed Common Stock
M-Exempt
Farrell Michael J.
Chief Executive Officer
CEO / President 8 009
Value: $814.0K
Oct 07, 2025
Sell
ResMed Common Stock
S-Sale
Farrell Michael J.
Chief Executive Officer
CEO / President 8 009
Value: $2.27M
Oct 07, 2025
Buy
ResMed Common Stock Options
M-Exempt
Farrell Michael J.
Chief Executive Officer
CEO / President 8 009
Value: $814.0K
Oct 07, 2025
Buy
ResMed Common Stock Options
M-Exempt
Farrell Michael J.
Chief Executive Officer
CEO / President 8 009
Value: $814.0K
Oct 07, 2025
Sell
ResMed Common Stock
S-Sale
Farrell Michael J.
Chief Executive Officer
CEO / President 8 009
Value: $2.27M
Oct 07, 2025
Buy
ResMed Common Stock
M-Exempt
Farrell Michael J.
Chief Executive Officer
CEO / President 8 009
Value: $814.0K
Oct 01, 2025
Buy
ResMed Common Stock
M-Exempt
Sandercock Brett
Chief Financial Officer
C-Suite Officer 2 000
Value: $203.3K
Oct 01, 2025
Sell
ResMed Common Stock
S-Sale
Sandercock Brett
Chief Financial Officer
C-Suite Officer 3 000
Value: $823.1K
Oct 01, 2025
Buy
ResMed Common Stock Options
M-Exempt
Sandercock Brett
Chief Financial Officer
C-Suite Officer 2 000
Value: $203.3K
Oct 01, 2025
Buy
ResMed Common Stock Options
M-Exempt
Sandercock Brett
Chief Financial Officer
C-Suite Officer 2 000
Value: $203.3K
Oct 01, 2025
Sell
ResMed Common Stock
S-Sale
Sandercock Brett
Chief Financial Officer
C-Suite Officer 3 000
Value: $823.1K
Oct 01, 2025
Buy
ResMed Common Stock
M-Exempt
Sandercock Brett
Chief Financial Officer
C-Suite Officer 2 000
Value: $203.3K
Oct 01, 2025
Sell
ResMed Common Stock
S-Sale
Rider Michael J
Global General Counsel
Officer 100
Value: $27.4K
Oct 01, 2025
Sell
ResMed Common Stock
S-Sale
Rider Michael J
Global General Counsel
Officer 100
Value: $27.4K
Sep 08, 2025
Buy
ResMed Common Stock
M-Exempt
Farrell Michael J.
Chief Executive Officer
CEO / President 8 009
Value: $814.0K
Sep 08, 2025
Sell
ResMed Common Stock
S-Sale
Farrell Michael J.
Chief Executive Officer
CEO / President 8 009
Value: $2.23M
Sep 08, 2025
Buy
ResMed Common Stock Options
M-Exempt
Farrell Michael J.
Chief Executive Officer
CEO / President 8 009
Value: $814.0K
Sep 08, 2025
Buy
ResMed Common Stock Options
M-Exempt
Farrell Michael J.
Chief Executive Officer
CEO / President 8 009
Value: $814.0K
Sep 08, 2025
Sell
ResMed Common Stock
S-Sale
Farrell Michael J.
Chief Executive Officer
CEO / President 8 009
Value: $2.23M
Sep 08, 2025
Buy
ResMed Common Stock
M-Exempt
Farrell Michael J.
Chief Executive Officer
CEO / President 8 009
Value: $814.0K
Sep 02, 2025
Buy
ResMed Common Stock
A-Award
Mowad-nassar Nicole
Director
Director 241
Value: $65.3K
Sep 02, 2025
Buy
ResMed Common Stock
A-Award
Mowad-nassar Nicole
Director
Director 241
Value: $65.3K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT RESMED INC
ResMed
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use i...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
7.76% Jun 12
DHI
$146.71
7.57% Jun 10
PHM
$118.49
7.15% Jun 10
EAT
$140.46
17.39% Jun 05
TPR
$140.47
2.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE